Monte Rosa Therapeutics (GLUE) Pension (2020 - 2026)
Monte Rosa Therapeutics (GLUE) posted quarterly Pension of $5.3 million for Q1 2026, up 32.79% year-over-year from $4.0 million in Q1 2025, and little changed quarter-over-quarter from $5.3 million in Q4 2025.
Monte Rosa Therapeutics (GLUE) Pension (2020 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Pension history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- In Q1 2026, Pension rose 32.79% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 32.79% YoY), while the FY2025 annual figure was $5.3 million, up 42.22% from the prior year.
- Pension for Q1 2026 stood at $5.3 million, roughly flat from $5.3 million in the prior quarter.
- The five-year high for Pension was $6.9 million in Q4 2022, with the low at $1.5 million in Q3 2023.
- The 5-year median for Pension is $2.7 million (2023), against an average of $3.3 million.
- The sharpest annual moves came in 2023 and 2024: Pension sank 60.4% in 2023, then soared 94.29% in 2024.
- Monte Rosa Therapeutics' Pension stood at $6.9 million in 2022, then tumbled by 60.4% to $2.7 million in 2023, then surged by 36.45% to $3.7 million in 2024, then jumped by 42.22% to $5.3 million in 2025, then dropped by 0.09% to $5.3 million in 2026.
- Business Quant data shows GLUE's Pension at $5.3 million in Q1 2026, $5.3 million in Q4 2025, and $4.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Monte Rosa Therapeutics | 1.32 Bn | 688.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.24 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 6.85 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 5.98 Mn |
| Sep 30, 2021 | 2.00 Mn |